{"disease":{"id":"visual-suppression","name":"visual suppression"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04606355","title":"Autostereoscopic Dynamic Near Vision Testing","phase":"","overall_status":"SUSPENDED","enrollment_count":300,"lead_sponsor_name":"Alaska Blind Child Discovery","has_results":false},{"nct_id":"NCT04424225","title":"Visual Surround Suppression and Perceptual Expectation Under Psilocybin","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"University of Minnesota","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}